Urinary concentration of MMP2 is a promising biomarker of bladder cancer [5,43] and allows discrimination between BC patients and healthy subjects; however, it failed in accurate BC identification in the early stages of the disease. The gene discussed is MMP2; the disease is urinary bladder carcinoma.